Nanogen, Inc. is a diagnostics company with the mission to make the detection, the diagnosis, and the treatment and monitoring of an individual’s health easier and faster. The Company participates in two markets. The first is the molecular diagnostics market where the Company offers... more

MedMira Inc. (MedMira) is a Canadian medical biotechnology company engaged in the development, manufacturing and marketing of immunoassay-based, in-vitro diagnostic tests. MedMira specializes in developing and manufacturing diagnostic immunoassays for the detection of antigens and... more

Efoora is a proprietary developer of rapid, diagnostic tests. Efoora's flagship test, the Efoora rapid HIV test is an immunochromatographic assay that detects the presence of circulating human antibodies to the HIV-1 and HIV-2 virus in whole blood, serum, and plasma. It provides the end... more

Innovative Biosensors, Inc. is a pioneering developer and manufacturer of rapid detection technologies. IBI is seeing partners to accelerate product development and commercialization and to facilitate the sales distribution of current and future products. The BioFlash® system is... more

GeneFluidics is commercializing a novel molecular analysis platform that integrates bionanotechnology and microfluidics. The platform has two distinct yet synergistic components - electrochemical detection, embodied in a multichannel reader and plastic sensor chips, and automated sample... more

Cleveland Biosensors produces the BioFiniti® Point-Of-Care diagnostics system - rapid, quantitative, portable instruments using disposable microfluidic cartridges. BioFiniti® sensors provide a flexible platform for complex sample processing in a wide range of human, animal, food and... more

AMBRI Limited has operated since the late 1990s as a technology development Company focused solely on commercializing its patented Ion Channel Switch (ICS) technology as the basis of new biosensor products for medical and industrial applications. In 2006 the Company broadened its strategy... more

Universal Biosensors, Inc. (Universal Biosensors) is principally engaged in the research, development, manufacture and commercialization of a range of in vitro diagnostic tests for point-of-care use. The diagnostic blood test devices it is developing comprised a disposable test strip and... more

Oxford Biosensors has a clear objective: to create a new category in portable diagnostics for Primary Healthcare. Our aim is to introduce low complexity devices suited for use at the point of care by healthcare workers with minimal training required. Each strip will measure groups of... more

Sienna Capital Ltd is a biotechnology company with a focus on using world-class research to develop and commercialise biosensing technologies. Sienna values its strong working relationship with the scientific and administrative team at the Ludwig Institute for Cancer Research (LICR)... more